The use of LH activity to drive folliculogenesis: Exploring uncharted territories in ovulation induction

Human Reproduction Update

Volumn 8, Issue 6, 2002, Pages 543-557

  Filicori, Marco ^a   Cognigni, Graciela E ^a   Samara, Arafat ^a   Melappioni, Silvia ^a   Perri, Tiziana ^a   Cantelli, Barbara ^a   Parmegiani, Lodovico ^a   Pelusi, Giuseppe ^a   DeAloysio, Domenico ^a  

^a UNIVERSITY OF BOLOGNA   (Italy)

Author keywords

Folliculogenesis; LH activity; Luteinizing hormone; Ovarian function; Ovulation induction

Indexed keywords

CELL RECEPTOR; CHORIONIC GONADOTROPIN; CLOMIFENE CITRATE; FOLLITROPIN; FOLLITROPIN DERIVATIVE; GONADORELIN AGONIST; GONADORELIN ANTAGONIST; GONADORELIN DERIVATIVE; GONADOTROPIN DERIVATIVE; GONASI; GONASI F; HUMAN MENOPAUSAL GONADOTROPIN; LUTEINIZING HORMONE; LUTEINIZING HORMONE DERIVATIVE; METFORMIN; PROFASI HP; RECOMBINANT CHORIONIC GONADOTROPIN; RECOMBINANT FOLLITROPIN; RECOMBINANT LUTEINIZING HORMONE; TRIPTORELIN; UROFOLLITROPIN; RECOMBINANT PROTEIN;

COST OF REPRODUCTION; DRUG ACTIVITY; DRUG EFFECT; DRUG HALF LIFE; DRUG MECHANISM; DRUG POTENCY; DRUG RECEPTOR BINDING; DYNAMICS; FEMALE; FEMALE INFERTILITY; GRANULOSA CELL; HUMAN; HYPOGONADOTROPIC HYPOGONADISM; INFERTILITY THERAPY; LOW DRUG DOSE; LUTEINIZATION; OOCYTE; OVARY FOLLICLE DEVELOPMENT; OVARY FUNCTION; OVARY HYPERSTIMULATION; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PRIORITY JOURNAL; REGULATORY MECHANISM; REVIEW; SAFETY; HYPOGONADISM; OVARY; OVARY FOLLICLE; PHYSIOLOGY;

CHORIONIC GONADOTROPIN; FEMALE; HUMANS; HYPOGONADISM; LUTEINIZING HORMONE; MENOTROPINS; OVARIAN FOLLICLE; OVARY; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; RECOMBINANT PROTEINS; REPRODUCTIVE TECHNIQUES, ASSISTED;

EID: 0036864011     PISSN: 13554786     EISSN: None     Source Type: Journal    
DOI: 10.1093/humupd/8.6.543     Document Type: Review

References (104)

1. Adashi, E.Y. (1996) The ovarian follicular apparatus. In Adashi, E.Y., Rock, J.A. and Rosenwaks, Z. (eds), Reproductive Endocrinology, Surgery, and Technology. Lippincott-Raven, Philadelphia, pp. 17-40.
2. Agrawal, R., Conway, G.S., Engmann, L., Bekir, J.S. and Jacobs, H.S. (1998) Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization. Gynecol. Endocrinol., 12, 9-15.
3. Agrawal, R., Holmes, J. and Jacobs, H.S. (2000) Follicle-stimulating hormone or human menopausal gonadotropin for ovarian stimulation in in vitro fertilization cycles: a meta-analysis. Fertil. Steril., 73, 338-343.
4. Arguinzoniz, M., Duerr-Myers, L., Engrand, P., Piazzi, A. and Loumaye, E. (2000) The efficacy and safety of recombinant human luteinizing hormone for minimizing the number of pre-ovulatory follicles in WHO group I anovulatory women treated with rhFSH. Program of the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy, 2000, pp. 70-71, Abst. O-176.
5. Balasch, J., Miro, F., Burzaco, I., Casamitjana, R., Civico, S., Ballesca, J.L., Puerto, B. and Vanrell, J.A. (1995) The role of luteinizing hormone in human follicle development and oocyte fertility: evidence from in-vitro fertilization in a woman with long-standing hypogonadotrophic hypogonadism and using recombinant human follicle stimulating hormone. Hum. Reprod, 10, 1678-1683.
6. Balasch, J., Fabregues, F., Creus, M., Moreno, V., Puerto, B., Penarrubia, J., Carmona, F. and Vanrell, J.A. (1996) Pure and highly purified follicle-stimulating hormone alone or in combination with human menopausal gonadotrophin for ovarian stimulation after pituitary suppression in in-vitro fertilization. Hum. Reprod, 11, 2400-2404.
7. Balasch, J., Creus, M., Fabregues, F., Civico, S., Carmona, F., Puerto, B., Casamitjana, R. and Vanrell, J.A. (2001a) The effect of exogenous luteinizing hormone (LH) on oocyte viability: evidence from a comparative study using recombinant human follicle-stimulating hormone (FSH) alone or in combination with recombinant LH for ovarian stimulation in pituitary-suppressed women undergoing assisted reproduction. J Assist. Reprod. Genet., 18, 250-256.
8. Balasch, J., Vidal, E., Penarrubia, J., Casamitjana, R., Carmona, F., Creus, M., Fabregues, F. and Vanrell, J.A. (2001b) Suppression of LH during ovarian stimulation: analysing threshold values and effects on ovarian response and the outcome of assisted reproduction in down-regulated women stimulated with recombinant FSH. Hum. Reprod., 16, 1636-1643.
9. Barnes, R.B., Namnoum, A.B., Rosenfield, R.L. and Layman, L.C. (2002) The role-of LH and FSH in ovarian androgen secretion and ovarian follicular development: clinical studies in a patient with isolated FSH deficiency and multicystic ovaries. Hum. Reprod., 17, 88-91.
10. Ben-Amor, A.-F. (2000) The effect of luteinizing hormone administered during late follicular phase in normo-ovulatory women undergoing in-vitro fertilization. Program of the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy, 2000, p. 46, Abst. 116.
11. Benadiva, C.A., Davis, O., Kligman, I., Moomjy, M., Liu, H.C. and Rosenwaks, Z. (1997) Withholding gonadotropin administration is an effective alternative for the prevention of ovarian hyperstimulation syndrome. Fertil. Steril., 67, 724-727.
12. Blankstein, J., Shalev, J., Saadon, T., Kukia, E.E., Rabinovici, J., Pariente, C., Lunenfeld, B., Serr, D.M. and Mashiach, S. (1987) Ovarian hyperstimulation syndrome: prediction by number and size of preovulatory ovarian follicles. Fertil. Steril., 47, 597-602.
13. Brailly, S., Gougeon, A., Milgrom, E., Bomsel, H.O. and Papiernik, E. (1981) Androgens and progestins in the human ovarian follicle: differences in the evolution of preovulatory, healthy nonovulatory, and atretic follicles. J. Clin. Endocrinol. Metab., 53, 128-134.
14. Burgues, S. (2001) The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain. Hum. Reprod., 16, 2525-2532.
15. Campbell, B.K., Dobson, H., Baird, D.T. and Scaramuzzi, R.J. (1999) Examination of the relative role of FSH and LH in the mechanism of ovulatory follicle selection in sheep. J. Reprod. Fertil., 117, 355-367.
16. Chetkowski, R.J., Kiltz, R.J. and Salyer, W.R. (1997) In premature luteinization, progesterone induces secretory transformation of the endometrium without impairment of embryo viability. Fertil. Steril., 68, 292-297.
17. Copperman, A.B., Horowitz, G.M., Kaplan, P., Scott, R.T., Navot, D. and Hofmann, G.E. (1995) Relationship between circulating human chorionic gonadotropin levels and premature luteinization in cycles of controlled ovarian hyperstimulation. Fertil. Steril., 63, 1267-1271.
18. Couzinet, B., Lestrat, N., Brailly, S., Forest, M. and Schaison, G. (1988) Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency. J. Clin. Endocrinol. Metab., 66, 552-556.
19. Daya, S., Gunby, J., Hughes, E.G., Collins, J.A. and Sagle, M.A. (1995) Follicle-stimulating hormone versus human menopausal gonadotropin for in vitro fertilization cycles: a meta-analysis. Fertil. Steril., 64, 347-354.
20. De Leo, V., la Marca, A., Ditto, A., Morgante, G. and Cianci, A. (1999) Effects of metformin on gonadotropin-induced ovulation in women with polycystic ovary syndrome. Fertil. Steril., 72, 282-285.
21. Dorrington, J.H. and Armstrong, D.T. (1979) Effects of FSH on gonadal functions. Rec. Prog. Hormone Res., 35, 301-342.
22. Driscoll, G.L., Tyler, J.P., Hangan, J.T., Fisher, P.R., Birdsall, M.A. and Knight, D.C. (2000) A prospective, randomized, controlled, double-blind, double-dummy comparison of recombinant and urinary HCG for inducing oocyte maturation and follicular luteinization in ovarian stimulation. Hum. Reprod., 15, 1305-1310.
23. Eldar, G.T., Robertson, D.M., Cahir, N., Groome, N., Gabbe, M.P., Maclachlan, V. and Healy, D.L. (2000) Relationship between serum inhibin A and B and ovarian follicle development after a daily fixed dose administration of recombinant follicle-stimulating hormone. J. Clin. Endocrinol. Metab., 85, 607-613.
24. Espey, L.L. (1974) Ovarian proteolytic enzymes and ovulation. Biol. Reprod., 10, 216-235.
25. Fanchin, R., de Ziegler, D., Taieb, J., Hazout, A. and Frydman, R. (1993) Premature elevation of plasma progesterone alters pregnancy rates of in vitro fertilization and embryo transfer. Fertil. Steril., 59, 1090-1094.
26. Filicori, M. (1994) Gonadotrophin-releasing hormone agonists. A guide to use and selection. Drugs, 48, 41-58.
27. Filicori, M. (1996) Clinical review 81: Gonadotropin-releasing hormone analogs in ovulation induction: current status and perspectives. J. Clin. Endocrinol. Metab., 81, 2413-2416.
28. Filicori, M. (1999) The role of luteinizing hormone in folliculogenesis and ovulation induction. Fertil. Steril., 71, 405-414.
29. Filicori, M. and Cognigni, G.E. (2001) Clinical review 126: roles and novel regimens of luteinizing hormone and follicle-stimulating hormone in ovulation induction. J. Clin. Endocrinol. Metab., 86, 1437-1441.
30. Filicori, M., Santoro, N., Merriam, G.R. and Crowley, W.F.J. (1986) Characterization of the physiological pattern of episodic gonadotropin secretion throughout the human menstrual cycle. J. Clin. Endocrinol. Metab., 62, 1136-1144.
31. Filicori, M., Flamigni, C., Meriggiola, M.C., Cognigni, G., Valdiserri, A., Ferrari, P. and Campaniello, E. (1991) Ovulation induction with pulsatile gonadotropin-releasing hormone: technical modalities and clinical, perspectives. Fertil. Steril., 56, 1-13.
32. Filicori, M., Flamigni, C., Dellai, P., Cognigni, G., Michelacci, L., Arnone, R., Sambataro, M. and Falbo, A. (1994) Treatment of anovulation with pulsatile gonadotropin-releasing hormone: prognostic factors and clinical results in 600 cycles. J. Clin. Endocrinol. Metab., 79, 1215-1220.
33. Filicori, M., Flamigni, C., Cognigni, G.E., Falbo, A., Arnone, R., Capelli, M., Pavani, A., Mandini, M., Calderoni, P. and Brondelli, L. (1996) Different gonadotropin and leuprorelin ovulation induction regimens markedly affect follicular fluid hormone levels and folliculogenesis. Fertil. Steril., 65, 387-393.
34. Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W. and Tabarelli De Fatis, C. (1999a) Low-dose human chorionic gonadotropin therapy can improve sensitivity to exogenous follicle-stimulating hormone in patients with secondary amenorrhea. Fertil. Steril., 72, 1118-1120.
35. Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., Tabarelli De Fatis, C. and Pocognoli, P. (1999b) Luteinizing hormone activity supplementation enhances follicle-stimulating hormone efficacy and improves ovulation induction outcome. J. Clin. Endocrinol. Metab., 84, 2659-2663.
36. Filicori, M., Cognigni, G.E., Taraborrelli, S., Spettoli, D., Ciampaglia, W., Tabarelli De Fatis, C., Pocognoli, P., Cantelli, B. and Boschi, S. (2001) Luteinizing hormone activity in menotropins optimizes folliculogenesis and treatment in controlled ovarian stimulation. J. Clin. Endocrinol. Metab., 86, 337-343.
37. Filicori, M., Cognigni, G.E., Pocognoli, P., Tabarelli, C., Spettoli, D., Taraborrelli, S., Ciampaglia, W. (2002a) Modulation of folliculogenesis and steroidogenesis in women by graded menotropin administration. Hum. Reprod. 17, 2009-2015.
38. Filicori, M., Cognigni, G.E., Tabarelli, C., Pocognoli, P., Taraborrelli, S., Spettoli, D. and Ciampaglia, W. (2002b) Stimulation and growth of antral ovarian follicles by selective LH activity administration in women. J. Clin. Endocrinol. Metab., 87, 1156-1161.
39. Filicori, M., Cognigni, G.E., Taraborrelli, S., Parmegiani, L., Bernardi, S., Tabarelli, C. and Ciampaglia, W. (2002c) Pregnancy after low-dose human chorionic gonadotropin alone to support ovarian folliculogenesis. Fertil. Steril., 78, 414-416.
40. Gordon, U.D., Harrison, R.F., Fawzy, M., Hennelly, B. and Gordon, A.C. (2001) A randomized prospective assessor-blind evaluation of luteinizing hormone dosage and in vitro fertilization outcome. Fertil. Steril., 75, 324-331.
41. Gulyas, B.J., Hodgen, G.D., Tullner, W.W. and Ross, G.T. (1977) Effects of fetal or maternal hypophysectomy on endocrine organs and body weight in infant rhesus monkeys (Macaca mulatta): with particular emphasis on oogenesis. Biol. Reprod., 16, 216-227.
42. Hall, J.E., Schoenfeld, D.A., Martin, K.A. and Crowley, W.F.J. (1992) Hypothalamic gonadotropin-releasing hormone secretion and follicle-stimulating hormone dynamics during the luteal-follicular transition. J. Clin. Endocrinol. Metab., 74, 600-607.
43. Hillier, S.G. (1994) Current concepts of the roles of follicle stimulating hormone and luteinizing hormone in folliculogenesis. Hum. Reprod., 9, 188-191.
44. Hillier, S.G., Whitelaw, P.F. and Smyth, C.D. (1994) Follicular oestrogen synthesis: the 'two-cell, two-gonadotrophin' model revisited. Mol. Cell. Endocrinol., 100, 51-54.
45. Hofmann, G.E., Bentzien, F., Bergh, P.A., Garrisi, G.J., Williams, M.C., Guzman, I. and Navot, D. (1993a) Premature luteinization in controlled ovarian hyperstimulation has no adverse effect on oocyte and embryo quality. Fertil. Steril., 60, 675-679.
46. Hofmann, G.E., Bergh, P.A., Guzman, I., Masuku, S. and Navot, D. (1993b) Premature luteinization is not eliminated by pituitary desensitization with leuprolide acetate in women undergoing gonadotrophin stimulation who demonstrated premature luteinization in a prior gonadotrophin-only cycle. Hum. Reprod., 8, 695-698.
47. Imthurn, B., Macas, E., Rosselli, M. and Keller, P.J. (1996) Nuclear maturity and oocyte morphology after stimulation with highly purified follicle stimulating hormone compared to human menopausal gonadotrophin. Hum. Reprod., 11, 2387-2391.
48. Jaatinen, T.A., Penttila, T.L., Kaipia, A., Ekfors, T., Parvinen, M. and Toppari, J. (1994) Expression of inhibin alpha, beta A and beta B messenger ribonucleic acids in the normal human ovary and in polycystic ovarian syndrome. J. Endocrinol., 143, 127-137.
49. Jakubowicz, D.J., Seppala, M., Jakubowicz, S., Rodriguez-Armas, O., Rivas-Santiago, A., Koistinen, H., Koistinen, R. and Nestler, J.E. (2001) Insulin reduction with metformin increases luteal phase serum glycodelin and insulin-like growth factor-binding protein 1 concentrations and enhances uterine vascularity and blood flow in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 86, 1126-1133.
50. Jakubowicz, D.J., Iuorno, M.J., Jakubowicz, S., Roberts, K.A. and Nestler, J.E. (2002) Effects of metformin on early pregnancy loss in the polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 87, 524-529.
51. Lawrence, T.S., Dekel, N. and Beers, W.H. (1980) Binding of human chorionic gonadotropin by rat cumuli oophori and granulosa cells: a comparative study. Endocrinology, 106, 1114-1118.
52. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. and Munafo, A. (1998a) Clinical pharmacology of recombinant human luteinizing hormone: Part I. Pharmacokinetics after intravenous administration to healthy female volunteers and comparison with urinary human luteinizing hormone. Fertil. Steril., 69, 189-194.
53. le Cotonnec, J.Y., Porchet, H.C., Beltrami, V. and Munafo, A. (1998b) Clinical pharmacology of recombinant human luteinizing hormone: Part II. Bioavailability of recombinant human luteinizing hormone assessed with an immunoassay and an in vitro bioassay. Fertil. Steril., 69, 195-200.
54. Legro, R.S., Ary, B.A., Paulson, R.J., Stanczyk, F.Z. and Sauer, M.V. (1993) Premature luteinization as detected by elevated serum progesterone is associated with a higher pregnancy rate in donor oocyte in-vitro fertilization. Hum. Reprod., 8, 1506-1511.
55. Loumaye, E., Duerr-Myers, L., Engrand, P., Piazzi, A. and Arguinzoniz, M. (2000) Minimizing the number of pre-ovulatory follicles in WHO group II anovulatory women over-responding to FSH with recombinant human luteinizing hormone. Program of the 15th Annual Meeting of the European Society of Human Reproduction and Embryology, Bologna, Italy, 2000, p. 71, Abst. O-177.
56. Louvet, J.P., Harman, S.M., Schrieber, J.R. and Ross, G.T. (1975) Evidence of a role of androgens in follicular maturation. Endocrinology, 97, 366-372.
57. Mannaerts, B., de Leeuw, R., Geelen, J., Van Ravestein, A., Van Wezenbeek, P., Schuurs, A. and Kloosterboer, H. (1991) Comparative in vitro and in vivo studies on the biological characteristics of recombinant human follicle-stimulating hormone. Endocrinology, 129, 2623-2630.
58. Mercan, R., Mayer, J.F., Walker, D., Jones, S., Oehninger, S., Toner, J.P. and Muasher, S.J. (1997) Improved oocyte quality is obtained with follicle stimulating hormone alone than with follicle stimulating hormone/human menopausal gonadotrophin combination. Hum. Reprod., 12, 1886-1889.
59. Nardo, L.G., Rai, R., Backos, M., El Gaddal, S. and Regan, L. (2002) High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil. Steril., 77, 348-352.
60. Navot, D., Relou, A., Birkenfeld, A., Rabinowitz, R., Brzezinski, A. and Margalioth, E.J. (1988) Risk factors and prognostic variables in the ovarian hyperstimulation syndrome. Am. J. Obstet. Gynecol., 159, 210-215.
61. Nestler, J.E., Barlascini, C.O., Matt, D.W., Steingold, K.A., Plymate, S.R., Clore, J.N. and Blackard, W.G. (1989) Suppression of serum insulin by diazoxide reduces serum testosterone levels in obese women with polycystic ovary syndrome. J. Clin. Endocrinol. Metab., 68, 1027-1032.
62. Nestler, J.E., Jakubowicz, D.J., Evans, W.S. and Pasquali, R. (1998) Effects of metformin on spontaneous and clomiphene-induced ovulation in the polycystic ovary syndrome. N. Engl. J. Med., 338, 1876-1880.
63. Ng, E.H., Lau, E.Y., Yeung, W.S. and Ho, P.C. (2001) HMG is as good as recombinant human FSH in terms of oocyte and embryo quality: a prospective randomized trial. Hum. Reprod., 16, 319-325.
64. Peluso, J.J., Durkee, T. and Gruenberg, M.L. (1984) The effect of an LH pulse on 3H-thymidine incorporation into cultured ovaries of metestrous rats. Cell Tissue Res., 238, 159-163.
65. Rani, C.S., Salhanick, A.R. and Armstrong, D.T. (1981) Follicle-stimulating hormone induction of luteinizing hormone receptor in cultured rat granulosa cells: an examination of the need for steroids in the induction process. Endocrinology, 108, 1379-1385.
66. Roberts, V.J., Barth, S., el-Roeiy, A. and Yen, S.S. (1993) Expression of inhibin/activin subunits and follistatin messenger ribonucleic acids and proteins in ovarian follicles and the corpus luteum during the human menstrual cycle. J. Clin. Endocrinol. Metab., 77, 1402-1410.
67. Rodgers, M., Mitchell, R., Lambert, A., Peers, N. and Robertson, W.R. (1992) Human chorionic gonadotrophin contributes to the bioactivity of Pergonal. Clin. Endocrinol. (Oxf.), 37, 558-564.
68. Rodgers, M., McLoughlin, J., Peers, N., Anderson, J., Woods, P., Mitchell, G.G. and Robertson, W.R. (1994) Accumulation of human chorionic gonadotrophin in the serum of patients during in-vitro fertilization treatment cycles with Pergonal. Hum. Reprod., 9, 638-642.
69. Schoolcraft, W.B., Gardner, D.K., Lane, M., Schlenker, T., Hamilton, F. and Meldrum, D.R. (1999) Blastocyst culture and transfer: analysis of results and parameters affecting outcome in two in vitro fertilization programs. Fertil. Steril., 72, 604-609.
70. Schoot, D.C., Coelingh, B.H., Mannaerts, B.M., Lamberts, S.W., Bouchard, P. and Fauser, B.C. (1992) Human recombinant follicle-stimulating hormone induces growth of preovulatory follicles without concomitant increase in androgen and estrogen biosynthesis in a woman with isolated gonadotropin deficiency. J. Clin. Endocrinol. Metab., 74, 1471-1473.
71. Schoot, D.C., Harlin, J., Shoham, Z., Mannaerts, B.M., Lahlou, N., Bouchard, P., Bennink, H.J. and Fauser, B.C. (1994) Recombinant human follicle-stimulating hormone and ovarian response in gonadotrophin-deficient women. Hum. Reprod., 9, 1237-1242.
72. Shima, K., Kitayama, S. and Nakano, R. (1987) Gonadotropin binding sites in human ovarian follicles and corpora lutea during the menstrual cycle. Obstet. Gynecol., 69, 800-806.
73. Shoham, Z., Balen, A., Patel, A. and Jacobs, H.S. (1991) Results of ovulation induction using human menopausal gonadotropin or purified follicle-stimulating hormone in hypogonadotropic hypogonadism patients. Fertil. Steril., 56, 1048-1053.
74. Shoham, Z., Jacobs, H.S. and Insler, V. (1993) Luteinizing hormone: its role, mechanism of action, and detrimental effects when hypersecreted during the follicular phase. Fertil. Steril., 59, 1153-1161.
75. Shulman, A., Ghetler, Y., Beyth, Y. and Ben Nun, I. (1996) The significance of an early (premature) rise of plasma progesterone in in vitro fertilization cycles induced by a 'long protocol' of gonadotropin releasing hormone analogue and human menopausal gonadotropins. J Assist. Reprod. Genet., 13, 207-211.
76. Sills, E.S., Levy, D.P., Moomjy, M., McGee, M. and Rosenwaks, Z. (1999) A prospective, randomized comparison of ovulation induction using highly purified follicle-stimulating hormone alone and with recombinant human luteinizing hormone in in-vitro fertilization. Hum. Reprod., 14, 2230-2235.
77. Silverberg, K.M., Burns, W.N., Olive, D.L., Riehl, R.M. and Schenken, R.S. (1991) Serum progesterone levels predict success of in vitro fertilization/embryo transfer in patients stimulated with leuprolide acetate and human menopausal gonadotropins. J. Clin. Endocrinol. Metab., 73, 797-803.
78. Stokman, P.G., de Leeuw, R., van den Wijngaard, H.A., Kloosterboer, H.J., Vemer, H.M. and Sanders, A.L. (1993) Human chorionic gonadotropin in commercial human menopausal gonadotropin preparations. Fertil. Steril., 60, 175-178.
79. Strehler, E., Abt, M., El Danasouri, I., De Santo, M. and Sterzik, K. (2001) Impact of recombinant follicle-stimulating hormone and human menopausal gonadotropins on in vitro fertilization outcome. Fertil. Steril., 75, 332-336.
80. Sullivan, M.W., Stewart-Akers, A., Krasnow, J.S., Berga, S.L. and Zeleznik, A.J. (1999) Ovarian responses in women to recombinant follicle-stimulating hormone and luteinizing hormone (LH): a role for LH in the final stages of follicular maturation. J. Clin. Endocrinol. Metab., 84, 228-232.
81. Teissier, M.P., Chable, H., Paulhac, S. and Aubard, Y. (1999) Recombinant human follicle stimulating hormone versus human menopausal gonadotrophin induction: effects in mature follicle endocrinology. Hum. Reprod., 14, 2236-2241.
82. The European and Israeli Study Group on Highly Purified Menotropin versus Recombinant Follicle-Stimulating Hormone (2002) Efficacy and safety of highly purified menotropin versus recombinant follicle-stimulating hormone in in vitro fertilization/intracytoplasmic sperm injection cycles: a randomized, comparative trial. Fertil. Steril. 78, 520-528.
83. The European Recombinant Human Chorionic Gonadotrophin Study Group (2000) Induction of final follicular maturation and early luteinization in women undergoing ovulation induction for assisted reproduction treatment - recombinant HCG versus urinary HCG. Hum. Reprod., 15, 1446-1451.
84. The European Recombinant Human LH Study Group (1998) Recombinant human luteinizing hormone (LH) to support recombinant human follicle-stimulating hormone (FSH)-induced follicular development in LH- and FSH-deficient anovulatory women: a dose-finding study. J. Clin. Endocrinol. Metab., 83, 1507-1514.
85. The European Recombinant LH Study Group (2001) Human recombinant luteinizing hormone is as effective as, but safer than, urinary human chorionic gonadotropin in inducing final follicular maturation and ovulation in in vitro fertilization procedures: results of a multicenter double-blind study. J. Clin. Endocrinol. Metab., 86, 2607-2618.
86. Thompson, K.A., LaPolt, P.S., River, J., Henderson, G., Dahl, K.D. and Meldrum, D.R. (1995) Gonadotropin requirements of the developing follicle. Fertil. Steril., 63, 273-276.
87. Tortoriello, D.V., McGovern, P.G., Colon, J.M., Skurnick, J.H., Lipetz, K. and Santoro, N. (1998) 'Coasting' does not adversely affect cycle outcome in a subset of highly responsive in vitro fertilization patients. Fertil. Steril., 69, 454-460.
88. Trinchard-Lugan, I., Khan, A. and Porchet, H.C. (2002) Pharmacokinetics and pharmacodynamics of recombinant human chorionic gonadotrophin in healthy male and female volunteers. Reproductive BioMedicine Online, 4, 106-115.
89. Ubaldi, F., Albano, C., Peukert, M., Riethmuller-Winzen, H., Camus, M., Smitz, J., Van Steirteghem, A. and Devroey, P. (1996a) Subtle progesterone rise after the administration of the gonadotrophin-releasing hormone antagonist cetrorelix in intracytoplasmic sperm injection cycles. Hum. Reprod., 11, 1405-1407.
90. Ubaldi, F., Camus, M., Smitz, J., Bennink, H.C., Van Steirteghem, A. and Devroey, P. (1996b) Premature luteinization in in vitro fertilization cycles using gonadotropin-releasing hormone agonist (GnRH-a) and recombinant follicle-stimulating hormone (FSH) and GnRH-a and urinary FSH. Fertil. Steril., 66, 275-280.
91. Uilenbroek, J.T., Woutersen, P.J. and van-der Schoot, P. (1980) Atresia of preovulatory follicles: gonadotropin binding and steroidogenic activity. Biol. Reprod., 23, 219-229.
92. van Sambrink, E.J. and Fauser, B.C. (1997) Urinary follicle-stimulating hormone for normogonadotropic clomiphene-resistant anovulatory infertility: prospective, randomized comparison between low dose step-up and step-down dose regimens. J. Clin. Endocrinol. Metab., 82, 3597-3602.
93. Veldhuis, J.D., Johnson, M.L. and Dufau, M.L. (1987) Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man. J. Clin. Endocrinol. Metab., 64, 1275-1282.
94. Weissman, A., Meriano, J., Ward, S., Gotlieb, L. and Casper, R.F. (1999) Intracytoplasmic sperm injection after follicle stimulation with highly purified human follicle-stimulating hormone compared with human menopausal gonadotropin. J. Assist. Reprod. Genet., 16, 63-68.
95. Werlin, L., Kelly, E.E., Weathersbee, P., Nebiolo, L. and Ferrande, L. (1999) A multi-center, randomized, comparative, open-label trial to assess the safety and efficacy of Gonal-F (r-hFSH) versus Gonal-F and recombinant human luteinizing hormone (r-hLH) in patients undergoing ICSI: preliminary data. Program of the 1999 Annual Meeting of the American Society for Reproductive Medicine, Toronto, Canada, 1999, pp. S12-13, Abst. O-032.
96. Westergaard, L.G., Laursen, S.B. and Andersen, C.Y. (2000) Increased risk of early pregnancy loss by profound suppression of luteinizing hormone during ovarian stimulation in normogonadotrophic women undergoing assisted reproduction. Hum. Reprod., 15, 1003-1008.
97. Westergaard, L.G., Erb, K., Laursen, S.B., Rex, S. and Rasmussen, P.E. (2001) Human menopausal gonadotropin versus recombinant follicle-stimulating hormone in normogonadotropic women down-regulated with a gonadotropin-releasing hormone agonist who were undergoing in vitro fertilization and intracytoplasmic sperm injection: a prospective randomized study. Fertil. Steril., 76, 543-549.
98. Williams, R.S. (2000) A multi-center trial comparing the efficacy of recombinant human follicle stimulating hormone (r-hFSH, Gonal F) versus r-hFSH plus recombinant human luteinizing hormone (r-hLH, Lhadi) in patients undergoing controlled ovarian hyperstimulation (COH) for assisted reproductive technologies (ART). Program of the 56th Annual Meeting of the American Society for Reproductive Medicine, abstract P-428, S228-S229.
99. Winter, J.S., Faiman, C., Hobson, W.C., Prasad, A.V. and Reyes, F.I. (1975) Pituitary-gonadal relations in infancy. I. Patterns of serum gonadotropin concentrations from birth to four years of age in man and chimpanzee. J. Clin. Endocrinol. Metab., 40, 545-551.
100. Yamoto, M., Minami, S., Nakano, R. and Kobayashi, M. (1992) Immunohistochemical localization of inhibin/activin subunits in human ovarian follicles during the menstrual cycle. J. Clin. Endocrinol. Metab., 74, 989-993.
101. Yong, E.L., Baird, D.T., Yates, R., Reichert-LE, J. and Hillier, S.G. (1992) Hormonal regulation of the growth and steroidogenic function of human granulosa cells. J. Clin. Endocrinol. Metab., 74, 842-849.
102. Yoshimura, Y. and Wallach, E.E. (1987) Studies of the mechanism(s) of mammalian ovulation. Fertil. Steril., 47, 22-34.
103. Zeleznik, A.J. and Hillier, S.G. (1984) The role of gonadotropins in the selection of the preovulatory follicle. Clin. Obstet. Gynecol., 27, 927-940.
104. Zeleznik, A.J., Midgley, A.R. Jr, and Reichert, L.E.J. (1974) Granulosa cell maturation in the rat: increased binding of human chorionic gonadotropin following treatment with follicle-stimulating hormone in vivo. Endocrinology, 95, 818-825.